Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vascular Effects of Eplerenone in Coronary Artery Disease With Preserved Ejection Fraction: A Double-Blind, Randomized, Placebo-Controlled Trial.
Sudano I, Naegele M, Roas S, Périat D, Frank M, Kouroedov A, Noll G, Lüscher TF, Enseleit F, Ruschitzka F, Flammer AJ. Sudano I, et al. Among authors: enseleit f. Clin Cardiol. 2016 May;39(5):285-90. doi: 10.1002/clc.22528. Epub 2016 Mar 14. Clin Cardiol. 2016. PMID: 26991772 Free PMC article. Clinical Trial.
Endothelin antagonists and heart failure.
Hürlimann D, Enseleit F, Noll G, Lüscher TF, Ruschitzka F. Hürlimann D, et al. Among authors: enseleit f. Curr Hypertens Rep. 2002 Feb;4(1):85-92. doi: 10.1007/s11906-002-0058-6. Curr Hypertens Rep. 2002. PMID: 11790297 Review.
Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).
Lüscher TF, Enseleit F, Pacher R, Mitrovic V, Schulze MR, Willenbrock R, Dietz R, Rousson V, Hürlimann D, Philipp S, Notter T, Noll G, Ruschitzka F; Heart Failure ET(A) Receptor Blockade Trial. Lüscher TF, et al. Among authors: enseleit f. Circulation. 2002 Nov 19;106(21):2666-72. doi: 10.1161/01.cir.0000038497.80095.e1. Circulation. 2002. PMID: 12438291 Clinical Trial.
Selective COX-2 inhibition improves endothelial function in coronary artery disease.
Chenevard R, Hürlimann D, Béchir M, Enseleit F, Spieker L, Hermann M, Riesen W, Gay S, Gay RE, Neidhart M, Michel B, Lüscher TF, Noll G, Ruschitzka F. Chenevard R, et al. Among authors: enseleit f. Circulation. 2003 Jan 28;107(3):405-9. doi: 10.1161/01.cir.0000051361.69808.3a. Circulation. 2003. PMID: 12551863 Clinical Trial.
81 results